Literature DB >> 32739407

Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO-EONS-EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up.

B Jordan1, A Margulies2, F Cardoso3, G Cavaletti4, H S Haugnes5, P Jahn6, E Le Rhun7, M Preusser8, F Scotté9, M J B Taphoorn10, K Jordan11.   

Abstract

Entities:  

Keywords:  CIPN; Clinical Practice Guidelines; central neuropathy; diagnosis; peripheral neurotoxicity; treatment

Year:  2020        PMID： 32739407     DOI： 10.1016/j.annonc.2020.07.003

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  36 in total

Review 1.  Updates in the Treatment of Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Jessica N Mezzanotte; Michael Grimm; Namrata V Shinde; Timiya Nolan; Lise Worthen-Chaudhari; Nicole O Williams; Maryam B Lustberg
Journal:  Curr Treat Options Oncol       Date:  2022-02-15

Review 2.  Neurological side effects of radiation therapy.

Authors:  J Jacob; L Feuvret; J-M Simon; M Ribeiro; L Nichelli; C Jenny; D Ricard; D Psimaras; K Hoang-Xuan; P Maingon
Journal:  Neurol Sci       Date:  2022-02-11       Impact factor: 3.307

3.  Neuroprotective Potential of Berberine Against Doxorubicin-Induced Toxicity in Rat's Brain.

Authors:  Ghadha Ibrahim Fouad; Kawkab A Ahmed
Journal:  Neurochem Res       Date:  2021-08-17       Impact factor: 3.996

4.  Improving Chemotherapy-Induced Peripheral Neuropathy in Patients with Breast or Colon Cancer after End of (Neo)adjuvant Therapy: Results from the Observational Study STEFANO.

Authors:  Matthias Zaiss; Jens Uhlig; Mark-Oliver Zahn; Thomas Decker; Helmar C Lehmann; Johanna Harde; Cathrin Hogrefe; Corinne Vannier; Norbert Marschner
Journal:  Oncol Res Treat       Date:  2021-09-08       Impact factor: 2.825

5.  Treatment strategy of oxaliplatin-induced peripheral neuropathy: a retrospective, nationwide study.

Authors:  Satoshi Yokoyama; Chihiro Nakagawa; Kouichi Hosomi
Journal:  Support Care Cancer       Date:  2021-10-01       Impact factor: 3.603

6.  Persistent neuropathy among early-stage breast cancer survivors in a population-based cohort.

Authors:  Kristina Engvall; Henrik Gréen; Mats Fredriksson; Elisabeth Åvall-Lundqvist
Journal:  Br J Cancer       Date:  2021-05-20       Impact factor: 7.640

Review 7.  Vitamin E for the Prevention of Chemotherapy-Induced Peripheral Neuropathy: A meta-Analysis.

Authors:  Jie Chen; Haili Shan; Wenjun Yang; Jiali Zhang; Haibin Dai; Ziqi Ye
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

Review 8.  Neoadjuvant Chemotherapy in Breast Cancer: An Advanced Personalized Multidisciplinary Prehabilitation Model (APMP-M) to Optimize Outcomes.

Authors:  Alba Di Leone; Daniela Terribile; Stefano Magno; Alejandro Martin Sanchez; Lorenzo Scardina; Elena Jane Mason; Sabatino D'Archi; Claudia Maggiore; Cristina Rossi; Annalisa Di Micco; Stefania Carnevale; Ida Paris; Fabio Marazzi; Valeria Masiello; Armando Orlandi; Antonella Palazzo; Alessandra Fabi; Riccardo Masetti; Gianluca Franceschini
Journal:  J Pers Med       Date:  2021-04-21

9.  Can exercise prevent the onset of chemotherapy-induced peripheral neuropathy?

Authors:  David Mizrahi
Journal:  Br J Cancer       Date:  2021-07-14       Impact factor: 9.075

10.  Ramipril Alleviates Oxaliplatin-Induced Acute Pain Syndrome in Mice.

Authors:  Hichem Bouchenaki; Aurore Danigo; Amandine Bernard; Flavien Bessaguet; Laurence Richard; Franck Sturtz; David Balayssac; Laurent Magy; Claire Demiot
Journal:  Front Pharmacol       Date:  2021-07-19       Impact factor: 5.810
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.